Last Updated on January 17, 2025 by The Health Master
Nicotine Pouches
The U.S. Food and Drug Administration (USFDA) has made an important move in the tobacco control landscape by granting USFDA approval for authorizing the marketing of 20 Zyn nicotine pouches.
This marks a landmark decision of the USFDA, as it’s the first time that such products like nicotine pouches have received USFDA approval in the United States.
Lower Risk:
This decision of the USFDA is based on a thorough review and evaluation, which has concluded that these nicotine pouches present a lower risk of cancer and other serious health problems as compared to cigarettes and other most traditional smokeless tobacco products, e.g., moist snuff and snus.
This reduced risk is because of lower levels of harmful ingredients in these nicotine pouches.
A Tobacco-Free Alternative
These nicotine pouches may be a unique alternative to conventional chewing tobacco.
It’s a nicotine pouch that does not contain any tobacco, which makes it a less harmful option for those seeking nicotine delivery without having any risk of tobacco.
What are Zyn nicotine pouches?
Zyn nicotine pouches deliver nicotine without containing any tobacco.
Are Zyn nicotine pouches safer than cigarettes?
The USFDA has determined that Zyn nicotine pouches have a lower risk of cancer and other serious health issues as compared to cigarettes and most smokeless tobacco products.
Health Waring: The consumption of tobacco products is injurious to health.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
USFDA bans use of Red No. 3 color in Food and Drugs
Indian Pharma and USFDA Compliance: An Update
USFDA proposes stricter testing for Asbestos in Talcum Powder Cosmetics
USFDA issues EIR to Aarti Drugs for Tarapur facility
USFDA issues VAI status to Biocon for Bengaluru API facility
USFDA issued Form 483 with two observations to Aurobindo for API plant
CDSCO approval granted for Eculizumab for rare disease
Key Notes on Revised Schedule M: Site Master File
USFDA bans use of Red No. 3 color in Food and Drugs
Clearer labelling of Oxygen Cylinders must
IPC to host 15th International Meeting of World Pharmacopoeias
Key Notes on Revised Schedule M: Biological products
PCI sets staff-to-student ratio for B.Pharm as 1:20
FDA Maharashtra seizes Drugs worth Rs 3 Lakh: DMROA
10 IV Fluids Banned in Hospitals: West Bengal
Drug Regulators to support Pharma Units for Schedule M Compliance
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
